Trigger Finger Trial
- Disease/Condition
- Trigger Finger
- Drug/Device/Intervention
- Excision of the A1 pulley
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Emory University
- Location
- Atlanta,Atlanta,Atlanta,Atlanta,Atlanta,Atlanta, United States of America
- Phase
- N/A
- Start date
- Jan 30, 2023
- End date
- Dec 01, 2027
- Enrollment
- 60 participants
Change in the pain score
Trigger finger is a common condition of the hand caused by the thickening of the A1 pulley or
 flexor tendon that alters the way in which the flexor tendon glides within the tendon sheath.
 
 The purpose of this study is to evaluate the efficacy of excision versus incision of the A1
 pulley for the trigger finger. Researchers hypothesize that excision of the A1 pulley would
 result in lower trigger finger recurrence rates, better pain relief, reduced soreness &
 stiffness as well as higher final Patient-Reported Outcomes Measurement (PROMs).
 
 This will be investigated via a randomized controlled study involving patients randomized in
 either of the aforementioned surgical treatment groups, which are both standards of care, at
 the Musculoskeletal Institute or at the Emory University Orthopaedic and Spine Hospital.
 Patients will then follow up in the clinic at 2 weeks, 6 weeks, 3 months, 6 months, and 1
 year to assess their outcomes measures stated in the protocol document. All work related to
 this project will take place at the Emory Sports Medicine Complex, Emory Executive Park,
 Emory Musculoskeletal Institute, and the Emory University Orthopaedic and Spine Hospital.
 Patients will not be compensated for participating in this study. Patients who are undergoing
 trigger finger surgery will be identified by their Orthopaedic surgeon who is a member of the
 study team. The surgeon will briefly discuss participation with the patient and make clear
 study expectations.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05251428
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05251428 through Pure Global AI's free database. This phase not specified trial is sponsored by Emory University and is currently Recruiting. The study focuses on Trigger Finger. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.